Molecular Imaging: Page 97

PET/CT-MR imaging offers advantages for oncology imaging

By Cynthia E. Keen

Trimodality PET/CT-MR imaging using a novel system to shuttle patients between scanners offers new insights into the diagnosis of cancer patients. How the configuration is being used at the University Hospital Zurich is described in an 8 October article in Magnetic Resonance Materials in Physics, Biology, and Medicine.

October 18, 2012

MILabs debuts SPECT system

By AuntMinnieEurope.com staff writers

Preclinical molecular imaging developer MILabs has developed U-SPECT Quick Start (U-SPECTQS), a molecular imaging system targeted at research institutions.

October 17, 2012

ImaginAb teams with Danish pharma firm

By AuntMinnieEurope.com staff writers

Imaging agent developer ImaginAb has inked a collaboration and commercialization agreement with Danish pharmaceutical firm H. Lundbeck.

October 8, 2012

AuntMinnieEurope.com Molecular Imaging Insider

By Philip Ward

October 8, 2012

EANM interview: PET offers immense clinical potential

By Philip Ward

Positron emission tomography (PET) has great potential for the future and promises to transform the practice of medical imaging, according to Dr. Stefano Fanti, Italy's national delegate for the European Association of Nuclear Medicine (EANM).

October 8, 2012

EHFG focuses on future of personalized medicine

By AuntMinnieEurope.com staff writers

The potential of personalized medicine remains underutilized, and healthcare systems do not need further specialized professionals but a "reconfiguration" of health professions, according to presentations given this week at the European Health Forum Gastein (EHFG) in Gastein, Austria.

October 2, 2012

Pearls and pitfalls can improve PET/CT interpretation

By Philip Ward

Everything that's bright on PET/CT scans is not pathological, and everything that's cold on these scans is not benign. This is one of the key points to remember when interpreting images, according to a group of specialists from one of Europe's leading cancer centers.

September 30, 2012

Carestream to sell preclinical imaging unit to Bruker

By AuntMinnieEurope.com staff writers

Carestream Health has signed an agreement to sell the preclinical in vivo imaging equipment product portfolio and related assets from its Molecular Imaging business to Bruker.

September 25, 2012

Advanced segmentation cuts plan errors for PET-guided IMRT

By Jude Dineley

Significant dosimetric errors in PET-guided planning of intensity-modulated radiation therapy (IMRT) can be avoided by using advanced segmentation algorithms, according to an article published in a September issue of Physics in Medicine and Biology. Use of these algorithms helps maintain patient safety and quality in a radiation oncology department.

September 23, 2012

ENCITE plans free workshop in Leiden

By AuntMinnieEurope.com staff writers

The European Network for Cell Imaging and Tracking Expertise (ENCITE) is organizing a workshop to present new technologies and methods in the field of imaging cell therapies, and also contrast agents.

September 17, 2012

WMIC: Molecular imaging cries out for better tools

By Cormac Sheridan

Multiscale imaging of the angiogenic network is uncovering new insights into tumor biology and challenging accepted anatomical models, but better tools -- both qualitative and validated -- are vital for multiparametric high-resolution mapping of structural, functional, cellular, and molecular imaging, according to a speaker at the World Molecular Imaging Congress (WMIC).

September 12, 2012

GE promotes phase III flutemetamol results

By AuntMinnieEurope.com staff writers

GE Healthcare said pooled results from phase III brain autopsy and biopsy studies using its F-18 flutemetamol PET imaging agent demonstrated a strong concordance between the flutemetamol images and beta amyloid brain pathology associated with Alzheimer's disease.

September 10, 2012

Previous Page

Page 97 of 122

Next Page